Patients eligible for lung cancer screening according to U.S. Preventive Services Task Force criteria were more likely to undergo screening if they were older, female, or a current smoker. Less than a quarter of them repeated screening in a year.
11 Oct 2022
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 Oct 2022
A 29-year-old woman requests advice after receipt of a direct-to-consumer genetic test result that included BRCA gene analysis. She has no breast symptoms and has not undergone any previous breast cancer screening. Following a physical exam and other findings, what is the most appropriate management?
13 Sep 2022
ACP's Performance Measurement Committee assessed cancer screening measures relevant to internal medicine physicians to determine whether they are evidence-based, methodologically sound, and clinically meaningful.
6 Sep 2022
A U.S. trial found that elderly patients whose physicians had taken a two-hour online course in communication skills were more likely to have had screening discussions focused on shared decision making during a primary care visit.
16 Aug 2022
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
1 Jul 2022
This month's issue considers coverage of Internal Medicine Meeting 2022, Leadership Day in Washington, D.C., and ACP's ninth COVID-19 forum.
1 Jul 2022
A reader responds to ACP Internist coverage about USPSTF recommendations on annual screening for lung cancer with CT.
1 May 2022
In March 2021, the U.S. Preventive Services Task Force (USPSTF) expanded eligibility for lung cancer screening by setting the benchmark at a 20 pack-year smoking history for those ages 50 to 80 years who are current smokers or former smokers who have quit within the past 15 years.
1 Mar 2022
A 28-year-old woman is seen to establish care. Medical history is significant for acute lymphoblastic leukemia diagnosed and treated at age 5 years; she has been leukemia free since completion of therapy. Following a physical exam and cervical cancer screening, what is the most appropriate additional survivorship assessment to perform next?
22 Feb 2022